Cytek Biosciences (CTKB) EBT (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Cytek Biosciences | - | - | 21.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -330.98% |
| Dec 31, 2025 | 48.11% |
| Sep 30, 2025 | -14.67% |
| Jun 30, 2025 | 39.86% |
| Mar 31, 2025 | -209.13% |
| Dec 31, 2024 | 6,475.16% |
| Sep 30, 2024 | 102.18% |
| Jun 30, 2024 | 20.09% |
| Mar 31, 2024 | -318.75% |
| Dec 31, 2023 | 198.23% |
| Sep 30, 2023 | 36.54% |
| Jun 30, 2023 | 27.05% |
| Mar 31, 2023 | -319.74% |
| Dec 31, 2022 | 122.38% |
| Sep 30, 2022 | 232.05% |
| Jun 30, 2022 | 57.58% |
| Mar 31, 2022 | -843.92% |
| Dec 31, 2021 | -78.60% |
| Sep 30, 2021 | -36.49% |
| Jun 30, 2021 | 2,049.34% |
| Mar 31, 2021 | -98.03% |
| Dec 31, 2020 | 11.76% |
| Sep 30, 2020 | 3,492.19% |